Stoke Therapeutics
STOK
#5004
Rank
A$2.64 B
Marketcap
A$40.50
Share price
-0.45%
Change (1 day)
-10.84%
Change (1 year)

Earnings for Stoke Therapeutics (STOK)

Earnings in 2026 (TTM): -A$0.36 Billion

According to Stoke Therapeutics's latest financial reports the company's current earnings are A$28.21 Million. In 2025 the company made an earning of -A$10.41 Million, an increase over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Stoke Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.36 Billion3302.37%
2025 -A$10.41 Million-92.26%
2024 -A$0.14 Billion-15.01%
2023 -A$0.16 Billion3.59%
2022 -A$0.16 Billion17.79%
2021 -A$0.13 Billion64.24%
2020 -A$78.93 Million61.62%
2019 -A$48.84 Million158.17%
2018 -A$18.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-35.80%๐Ÿ‡บ๐Ÿ‡ธ USA